Female Pattern Baldness Clinical Trial
Official title:
Efficacy of Fractional Needling Radiofrequency in Female Pattern Hair Loss, a Randomized Controlled Trial.
Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.
RF (Radiofrequency) based devices have also been shown to be successful in promoting hair growth, thought to occur through the induction of growth factors in the papillary dermis. Studying the effect of fractional needling radiofrequency in the treatment of female pattern hair loss will pave the way for more treatment options for this common disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00981461 -
Treatment of Androgenetic Alopecia in Females, 9 Beam
|
N/A | |
| Completed |
NCT01451021 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
|
Phase 2 | |
| Completed |
NCT01451138 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
|
Phase 2 | |
| Completed |
NCT03351322 -
ENERGI-F701 for Female Hair Loss Treatment
|
Phase 2 | |
| Completed |
NCT01451177 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
|
Phase 2 | |
| Completed |
NCT01451125 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
|
Phase 2 | |
| Recruiting |
NCT06333600 -
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05888922 -
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
|
Phase 3 | |
| Completed |
NCT01669746 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
|
Phase 2 | |
| Completed |
NCT01451099 -
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
|
Phase 2 | |
| Withdrawn |
NCT04379583 -
HairDx Analytical Validation Study
|
||
| Completed |
NCT01451190 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
|
Phase 2 | |
| Completed |
NCT01451047 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
|
Phase 2 | |
| Not yet recruiting |
NCT05824065 -
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
|
Phase 3 | |
| Not yet recruiting |
NCT02316418 -
Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)
|
N/A | |
| Completed |
NCT01016964 -
Treatment of Androgenetic Alopecia in Females, 12 Beam
|
N/A | |
| Completed |
NCT01451073 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)
|
Phase 2 | |
| Completed |
NCT01451151 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
|
Phase 2 | |
| Completed |
NCT04898166 -
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
|
||
| Completed |
NCT01451112 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
|
Phase 2 |